Functional Molecular Imaging of Tumors by Chemical Exchange Saturation Transfer MRI of 3-O-Methyl-D-Glucose

被引:63
作者
Rivlin, Michal [1 ]
Tsarfaty, Ilan [2 ]
Navon, Gil [1 ]
机构
[1] Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel
基金
以色列科学基金会;
关键词
MRI; breast cancer; chemical exchange saturation transfer; CEST; 3-O-Methyl-D-glucose; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; MAGNETIC-RESONANCE; D-GLUCOSE; 2-DEOXY-D-GLUCOSE; METABOLISM; CANCER; BRAIN; CEST; C-13;
D O I
10.1002/mrm.25467
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo evaluate the feasibility to detect tumors and metastases by the chemical exchange saturation transfer (CEST) MRI technique using 3-O-Methyl-D-glucose (3OMG), a nonmetabolizable derivative of glucose that is taken up rapidly and preferentially by tumors and is entirely excreted by the kidneys. MethodsIn vivo CEST MRI experiments were performed on a Bruker 7 Tesla Biospec on implanted orthotopic mammary tumors of mice before and following i.p. injection of 3OMG. The CEST images were generated by a series of gradient-echo images collected from a single 1 mm coronal slice after a 1.2 s presaturation pulse, applied at offsets of 1.2 ppm from the water and at B-1 power of 2.5 mu T. ResultsFollowing 3OMG (1.5 g/kg) i.p. injection, an enhanced CEST effect of approximately 20% was visualized at the tumor within a few minutes. The signal slowly declined reaching half of its maximum at approximately 80 min. ConclusionDue to the large CEST effect of 3OMG and its low toxicity 3OMG-CEST may serve for the detection of tumors and metastases in the clinic. Magn Reson Med 72:1375-1380, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1375 / 1380
页数:6
相关论文
共 26 条
[1]   Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer [J].
Chan, Kannie W. Y. ;
McMahon, Michael T. ;
Kato, Yoshinori ;
Liu, Guanshu ;
Bulte, Jeff W. M. ;
Bhujwalla, Zaver M. ;
Artemov, Dmitri ;
van Zijl, Peter C. M. .
MAGNETIC RESONANCE IN MEDICINE, 2012, 68 (06) :1764-1773
[2]   URINARY RECOVERY OF 3-METHYLGLUCOSE ADMINISTERED TO RATS [J].
CSAKY, TZ ;
GLENN, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1957, 188 (01) :159-162
[3]   Positron emission tomography scanning: Current and future applications [J].
Czernin, J ;
Phelps, ME .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :89-112
[4]   Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects [J].
Dwarakanath, B. S. ;
Singh, Dinesh ;
Banerji, Ajit K. ;
Sarin, Rajiv ;
Venkataramana, N. K. ;
Jalali, R. ;
Vishwanath, P. N. ;
Mohanti, B. K. ;
Tripathi, R. P. ;
Kalia, V. K. ;
Jain, Viney .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 :21-26
[5]  
Foehrenbach H, 2003, PRESSE MED, V32, P276
[6]   Molecular imaging of cancer with positron emission tomography [J].
Gambhir, SS .
NATURE REVIEWS CANCER, 2002, 2 (09) :683-693
[7]   PROTON MAGNETIC-RESONANCE STUDY OF HYDRATION OF GLUCOSE [J].
HARVEY, JM ;
SYMONS, MCR ;
NAFTALIN, RJ .
NATURE, 1976, 261 (5559) :435-436
[8]   Studies on the forms of d-glucose and their mutarotation [J].
Hudson, CS ;
Dale, JK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1917, 39 :320-328
[9]  
HWANG YC, 1992, CANCER RES, V52, P1259
[10]   METABOLIC STABILITY OF 3-O-METHYL-D-GLUCOSE IN BRAIN AND OTHER TISSUES [J].
JAY, TM ;
DIENEL, GA ;
CRUZ, NF ;
MORI, K ;
NELSON, T ;
SOKOLOFF, L .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (03) :989-1000